• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Wednesday, July 30, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Turns out lowly thymus may be saving your life

Bioengineer by Bioengineer
August 3, 2023
in Health
Reading Time: 3 mins read
0
ADVERTISEMENT
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

Many people couldn’t say where their thymus is, or what it does, and even doctors have long considered it expendable in adults. But new Harvard-led research suggests that the walnut-sized organ in the chest actually plays a vital role in immune health as we age, particularly in cancer prevention.

Kameron Kooshesh, David Sykes, David Scadden, and Karin Gustafsson at work in their lab at MGH.

Credit: Kris Snibbe/Harvard Staff Photographer

Many people couldn’t say where their thymus is, or what it does, and even doctors have long considered it expendable in adults. But new Harvard-led research suggests that the walnut-sized organ in the chest actually plays a vital role in immune health as we age, particularly in cancer prevention.

The study comparing data from patients who had their thymus removed with those who had not found that thymectomy patients had a nearly threefold higher risk of death from a variety of causes, including a twofold higher risk of cancer and a more modest increase in autoimmune diseases.

“The magnitude of risk was something we would have never expected,” said David Scadden, the Gerald and Darlene Jordan Professor of Medicine and professor in the Department of Stem Cell and Regenerative Biology, who led the study link published in The New England Journal of Medicine in collaboration with researchers at Massachusetts General Hospital.

“The primary reason why the thymus has an impact on overall health seems to be as a way to protect against the development of cancer.”

The thymus is the fastest-aging organ, according to Scadden. Most active in churning out T-cells during early childhood, it begins to atrophy into fatty tissue around puberty. That’s why, for many decades, scientists assumed it served a limited purpose in adulthood. It is typically removed due to issues with the organ itself, such as thymus cancer, or during other cardiothoracic surgeries because it’s located in front of the heart and is often in the surgeon’s way.

Yet in recent years scientists had started to suspect that the thymus plays an outsize role in our health as we age, by continuing to make T-cells that contribute to the diversity of the body’s overall T-cell population.

“This study demonstrates just how vital the thymus is to maintaining adult health,” Scadden said.

First author Kameron Kooshesh became intrigued by open questions about the adult thymus during a second-year neurology lecture at Harvard Medical School. He learned that surgical removal of the thymus is recommended in patients with the autoimmune disease myasthenia gravis as a way to halt T-cell-induced immune destruction of nerve endings. “And yet, clinical instruction on the surgery wards taught me that the thymus is thought to be vestigial in adults,” Kooshesh said. “These two philosophies seemed diametrically opposed, and I yearned to learn more.”

For the study, Kooshesh mined data from 1,146 adult patients who had undergone thymus removal, alongside demographically matched control patients who had undergone similar surgeries but kept their thymus. Kooshesh and Scadden worked in collaboration with Brody Foy, a biostatistician who helped direct the team’s statistical queries around the epidemiology of thymectomy patients, and Karin Gustafsson, an expert in T-cell biology. David Sykes at MGH helped the team facilitate patient blood draws.

In an analysis involving all patients with more than five years of follow-up, the rate of death was higher in the thymectomy group than in the general U.S. population ­— 9 percent vs. 5.2 percent, as was death due to cancer, or 2.3 percent vs. 1.5 percent.

In a subgroup of patients in whom T-cell production was measured, those who had had their thymus removed had less new production of T-cells, including both helper and cytotoxic T-cells. Those patients also had higher levels of pro-inflammatory cytokines, which are small signaling proteins associated with autoimmunity and cancer, in their blood.

“The magnitude of death and cancer in patients who had undergone thymectomy was the biggest surprise for me,” said Kooshesh, now an internal medicine resident at MGH. “The more we dug, the more we found: The results suggested to us that the lack of a thymus appears to perturb basic aspects of immune function.”

The analysis was facilitated by recent advances in rapid genetic sequencing of T-cell receptors (TCRs). The technology, called TCR sequencing, has enough resolution to allow scientists to not only identify different types of T cells, but also measure their diversity as a population overall.



Journal

New England Journal of Medicine

DOI

10.1056/NEJMoa2302892

Method of Research

Observational study

Subject of Research

People

Article Title

Health Consequences of Thymus Removal in Adults

Article Publication Date

3-Aug-2023

Share12Tweet8Share2ShareShareShare2

Related Posts

Merbecovirus S2 Vaccines Trigger Cross-Reactive MERS Protection

Merbecovirus S2 Vaccines Trigger Cross-Reactive MERS Protection

July 29, 2025
blank

Novel Plasma Synuclein Test Advances Parkinson’s Diagnosis

July 29, 2025

Obesity’s Impact on Pancreatic Surgery Outcomes Compared

July 28, 2025

Virion Movement in Sialoglycan-Cleaving Respiratory Viruses

July 28, 2025

POPULAR NEWS

  • Blind to the Burn

    Overlooked Dangers: Debunking Common Myths About Skin Cancer Risk in the U.S.

    57 shares
    Share 23 Tweet 14
  • USF Research Unveils AI Technology for Detecting Early PTSD Indicators in Youth Through Facial Analysis

    42 shares
    Share 17 Tweet 11
  • Dr. Miriam Merad Honored with French Knighthood for Groundbreaking Contributions to Science and Medicine

    45 shares
    Share 18 Tweet 11
  • Engineered Cellular Communication Enhances CAR-T Therapy Effectiveness Against Glioblastoma

    35 shares
    Share 14 Tweet 9

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Multi-Proteomic Analysis Reveals Host Risks in VZV

Merbecovirus S2 Vaccines Trigger Cross-Reactive MERS Protection

Cracking the Code of Cancer Drug Resistance

  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.